Year |
Citation |
Score |
2018 |
Messaritakis I, Nikolaou M, Politaki E, Koinis F, Lagoudaki E, Koutsopoulos A, Georgoulia N, Georgoulias V, Kotsakis A. Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment. Lung Cancer (Amsterdam, Netherlands). 124: 270-278. PMID 30268472 DOI: 10.1016/j.lungcan.2018.08.021 |
0.42 |
|
2018 |
Messaritakis I, Sfakianaki M, Papadaki C, Koulouridi A, Vardakis N, Koinis F, Hatzidaki D, Georgoulia N, Kladi A, Kotsakis A, Souglakos J, Georgoulias V. Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. PMID 30094617 DOI: 10.1007/s00280-018-3666-9 |
0.345 |
|
2014 |
Kalikaki A, Politaki H, Souglakos J, Apostolaki S, Papadimitraki E, Georgoulia N, Tzardi M, Mavroudis D, Georgoulias V, Voutsina A. KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer. Plos One. 9: e104902. PMID 25137394 DOI: 10.1371/journal.pone.0104902 |
0.304 |
|
2012 |
Maiuri P, Terriac E, Paul-Gilloteaux P, Vignaud T, McNally K, Onuffer J, Thorn K, Nguyen PA, Georgoulia N, Soong D, Jayo A, Beil N, Beneke J, Lim JC, Sim CP, et al. The first World Cell Race. Current Biology : Cb. 22: R673-5. PMID 22974990 DOI: 10.1016/J.Cub.2012.07.052 |
0.384 |
|
2012 |
Georgoulia NE, Mitchison TJ. Abstract 35: Breast cancer cell interactions Cancer Research. 72: 35-35. DOI: 10.1158/1538-7445.Am2012-35 |
0.386 |
|
Low-probability matches (unlikely to be authored by this person) |
2023 |
Ostoros G, Hettle R, Georgoulia N, Berktas M, Chander P, Diaz Perez I, Couto AM, Eichinger C, Field P, Morten P. Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis. Expert Review of Anticancer Therapy. 1-9. PMID 37850939 DOI: 10.1080/14737140.2023.2272645 |
0.221 |
|
2021 |
Spiliotaki M, Kallergi G, Nikolaou C, Xenidis N, Politaki E, Apostolaki S, Georgoulia N, Koinis F, Tsoukalas N, Hatzidaki D, Kotsakis A, Georgoulias V. Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestane. Cancer Chemotherapy and Pharmacology. PMID 33515073 DOI: 10.1007/s00280-020-04227-5 |
0.168 |
|
Hide low-probability matches. |